LiteVax
Akkersestraat 50
4061Bj Ophemert
NL
LiteVax
Foundation date
24/05/2012
Sector
#Biotechnology - TherapeuticsSubsector
Therapeutic areas
LiteVax BV is a biopharmaceutical company focusing on development and exploitation of innovative vaccine adjuvant concepts. Our mission is to contribute to global health by delivering improved adjuvants for vaccines against infectious and noninfectious diseases. People in developed and developing countries will benefit from better vaccines at lower costs.
Upcoming events
All events-
1012 '24
Next-Generation Synthetic Biology
Event by: VIB -
0204 '25
The Franco-Belgian Agrifood Summit
Event by: CCI France - Belgique -
0805 '25
Knowledge for Growth 2025
Event by: flanders.bio
Latest news
More news-
Muna Therapeutics Announces Strategic Alliance with GSK to Accelerate Development of Novel Treatments for Alzheimer’s Disease
Friday December 6th 2024
Read more
-
VUB and VIB launch new Bio Incubator Brussels on VUB campus
Friday December 6th 2024
Read more
-
Does the menstrual cycle influence the effect of chemotherapy?
Thursday December 5th 2024
Read more
Jobs
More jobs-
-
06/12/24
East Flanders
Head of Regulatory Science Seeds & Traits Belgium (m/f/d)
Permanent
BASF Belgium Coordination Center CommV -
More info?
Ellen Telleir
Communication Coordinator